Skip to main content
. 2021 Jun 10;17(1):135–139. doi: 10.1007/s11739-021-02784-y

Table 2.

Diagnosis of the patients

Patients with hematologic cancers N = 463, % Patients with solid cancers N = 463, %
Non-Hodgkin lymphoma 214 (46.2%) Breast cancer 128 (27.6%)
Multiple myeloma 74 (16%) Lung cancer 91 (19.7%)
Chronic lymphocytic leukemia 54 (11.7%) Colon cancer 59 (12.7%)
Acute myeloid leukemia 39 (8.4%) Prostate cancer 89 (19.2%)
Chronic myeloid leukemia 30 (6.4%) Skin cancer 29 (6.3%)
Hodgkin lymphoma 25 (5.4%) Stomach cancer 33 (7.1%)
Acute lymphoblastic leukemia 18 (3.9%) Brain cancer 19 (4.1%)
Hairy cell leukemia 9 (2%) Endometrial cancer 15 (3.2%)